bit.bio

Biotechnology · Cambridge, United Kingdom · Founded 2016 · Privately Held (backing)

Developer of a synthetic biology platform designed to provide human cells for research, drug discovery and cell therapy. bit.bio is based in Cambridge, United Kingdom and was founded in 2016. It was valued at $546 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $234 million across 1 recorded round; the latest was a $138 million later-stage round in Dec 2021.

PMV mark · valuation
$546.3M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$234.2M
Last round
Later Stage VC
Dec 2021

Who backs bit.bio?

35 investors
InvestorType
Innovate UKOther
Metaplanet HoldingsVenture capital
Tech Nation GroupOther
Puhua CapitalOther
Charles SonghurstOther
ARCH Venture PartnersVenture capital
Firstminute CapitalVenture capital
Cambridge Enterprise VenturesVenture capital
HawktailVenture capital
Foresite CapitalVenture capital
+ 25 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

bit.bio investors

35 investors are on record for bit.bio, including Innovate UK, Metaplanet Holdings, Tech Nation Group and Puhua Capital. By type, the record holds 7 venture capital firms and 2 hedge funds. The later-stage round in Dec 2021 drew 18 investors.

Free account
More of bit.bio with a free account
  • ·The complete investor list: 35 names
  • ·Watch bit.bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 35 firms already write checks for companies like bit.bio in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View